Showing 1 - 13 results of 13 for search 'Mohamed Shelan', query time: 0.05s
Refine Results
-
1
-
2
Five Fractions versus Seven Fractions SBRT for Intermediate- and High-Risk Prostate Cancer: A Propensity Score Matched Pair Analysis by Christina Schröder, Lucas Mose, Etienne Mathier, Daniel Rudolf Zwahlen, Daniel Matthias Aebersold, Robert Förster, Mohamed Shelan
Published 2023-12-01
Article -
3
Converting between the International Prostate Symptom Score (IPSS) and the Expanded Prostate Cancer Index Composite (EPIC) urinary subscales: modeling and external validation by Paul Windisch, Ivo Becker, Hongjian Tang, Christina Schröder, André Buchali, Daniel M. Aebersold, Daniel R. Zwahlen, Robert Förster, Mohamed Shelan
Published 2024-02-01
Article -
4
-
5
Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation by Beat Bojaxhiu, Arnoud J. Templeton, Olgun Elicin, Mohamed Shelan, Kathrin Zaugg, Marc Walser, Roland Giger, Daniel M. Aebersold, Alan Dal Pra
Published 2018-11-01
Article -
6
Dose-Volume Histogram Parameters and Quality of Life in Patients with Prostate Cancer Treated with Surgery and High-Dose Volumetric-Intensity-Modulated Arc Therapy to the Prostate... by Luca Hanke, Hongjian Tang, Christina Schröder, Paul Windisch, Ken Kudura, Mohamed Shelan, André Buchali, Stephan Bodis, Robert Förster, Daniel R. Zwahlen
Published 2023-06-01
Article -
7
-
8
HypoFocal SRT Trial: Ultra-hypofractionated focal salvage radiotherapy for isolated prostate bed recurrence after radical prostatectomy; single-arm phase II study; clinical trial p... by Daniel Zwahlen, Thomas Zilli, Etienne Mathier, Alexander Althaus, Jens Lustenberger, Constantinos Zamboglou, Berardino De Bari, Daniel M Aebersold, Matthias Guckenberger, Mohamed Shelan
Published 2024-01-01
Article -
9
Correlation between hematological parameters and PET/CT metabolic parameters in patients with head and neck cancer by Beat Bojaxhiu, Dubravko Sinovcic, Olgun Elicin, Arnoud J. Templeton, Mohamed Shelan, Jan Wartenberg, Ian Alberts, Axel Rominger, Daniel M. Aebersold, Kathrin Zaugg
Published 2022-08-01
Article -
10
Unplanned hospitalizations in patients with locoregionally advanced head and neck cancer treated with (chemo)radiotherapy with and without prophylactic percutaneous endoscopic gast... by Beat Bojaxhiu, Binaya K. Shrestha, Pascal Luterbacher, Olgun Elicin, Mohamed Shelan, Andrew J. S. Macpherson, Benjamin Heimgartner, Roland Giger, Daniel M. Aebersold, Kathrin Zaugg
Published 2020-12-01
Article -
11
Highly conformal combined radiotherapy with cisplatin and gemcitabine for treatment of loco-regionally advanced cervical cancer – a retrospective study by Nikola Cihoric, Alexandros Tsikkinis, Eugenia Vlaskou Badra, Markus Glatzer, Urban Novak, Amina Scherz, Mohamed Shelan, Ivan Soldatovic, Chittazhathu Kurian Kuruvilla Yojena, Daniel M. Aebersold, Kristina Lössl
Published 2017-12-01
Article -
12
Influencing Factors on Radiotherapy Outcome in Stage I-II Glottic Larynx Cancer—A Multicenter Study by Olgun Elicin, Ekin Ermiş, Ekin Ermiş, Christoph Oehler, Daniel M. Aebersold, Francesca Caparrotti, Frank Zimmermann, Gabriela Studer, Gabriela Studer, Guido Henke, Lukas Adam, Lukas Anschuetz, Mahmut Ozsahin, Matthias Guckenberger, Mohamed Shelan, Nuri Kaydıhan, Oliver Riesterer, Robin J. D. Prestwich, Thierry Spielmann, Roland Giger, Mehmet Şen
Published 2019-09-01
Article -
13
VoiceS: voice quality after transoral CO2 laser surgery versus single vocal cord irradiation for unilateral stage 0 and I glottic larynx cancer—a randomized phase III trial by Philipp Reinhardt, Roland Giger, Eberhard Seifert, Mohamed Shelan, Elena Riggenbach, Dario Terribilini, Andreas Joosten, Daniel H. Schanne, Daniel M. Aebersold, Peter Manser, Matthias S. Dettmer, Christian Simon, Esat M. Ozsahin, Raphaël Moeckli, Andreas Limacher, Francesca Caparrotti, Deepa Nair, Jean Bourhis, Martina A. Broglie, Abrahim Al-Mamgani, Olgun Elicin
Published 2022-10-01
Article